TreeWAS – Variant ID: rs2042126

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T78.3 Angioneurotic oedema	0.043	0.957	0.000
T78 Adverse effects, not elsewhere classified	0.035	0.965	0.000
T78.8 Other adverse effects, not elsewhere classified	0.033	0.967	0.000
T78.2 Anaphylactic shock, unspecified	0.030	0.970	0.000
T78.9 Adverse effect, unspecified	0.028	0.972	0.000
T78.1 Other adverse food reactions, not elsewhere classified	0.027	0.973	0.000
T78.0 Anaphylactic shock due to adverse food reaction	0.021	0.979	0.000
T78.4 Allergy, unspecified	0.020	0.980	0.000
F20.0 Paranoid schizophrenia	0.000	0.984	0.016
B02.2 Zoster with other nervous system involvement	0.000	0.985	0.015
F20 Schizophrenia	0.000	0.986	0.014
B02 Zoster [herpes zoster]	0.000	0.986	0.014
M54.36 Sciatica (Lumbar region)	0.014	0.986	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.987	0.013
F22 Persistent delusional disorders	0.000	0.987	0.013
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.000	0.987	0.013
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.987	0.013
B02.9 Zoster without complication	0.000	0.987	0.013
F22.0 Delusional disorder	0.000	0.987	0.013
S82.10 Fracture of upper end of tibia (closed)	0.000	0.988	0.012
F29 Unspecified nonorganic psychosis	0.000	0.988	0.012
B02.3 Zoster ocular disease	0.000	0.988	0.012
F22.9 Persistent delusional disorder, unspecified	0.000	0.988	0.012
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.988	0.012
M54.3 Sciatica	0.012	0.988	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.011	0.989	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.989	0.011
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.989	0.011
B02.8 Zoster with other complications	0.000	0.989	0.011
T46.1 Calcium-channel blockers	0.000	0.989	0.011
F20.8 Other schizophrenia	0.000	0.989	0.010
F20.6 Simple schizophrenia	0.000	0.990	0.010
F20.4 Postschizophrenic depression	0.000	0.990	0.010
F20.3 Undifferentiated schizophrenia	0.000	0.990	0.010
F20.1 Hebephrenic schizophrenia	0.000	0.990	0.010
F20.9 Schizophrenia, unspecified	0.000	0.990	0.010
B02.7 Disseminated zoster	0.000	0.990	0.010
B02.1 Zoster meningitis	0.000	0.990	0.010
B02.0 Zoster encephalitis	0.000	0.990	0.010
F23 Acute and transient psychotic disorders	0.000	0.990	0.010
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.010	0.990	0.000
F22.8 Other persistent delusional disorders	0.000	0.990	0.010
J33.8 Other polyp of sinus	0.000	0.990	0.010
F20.5 Residual schizophrenia	0.000	0.990	0.010
F28 Other nonorganic psychotic disorders	0.000	0.990	0.010
F24 Induced delusional disorder	0.000	0.990	0.010
F21 Schizotypal disorder	0.000	0.990	0.010
M54.30 Sciatica (Multiple sites in spine)	0.010	0.990	0.000
F20.2 Catatonic schizophrenia	0.000	0.990	0.010
M54.38 Sciatica (Sacral and sacrococcygeal region)	0.010	0.990	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.990	0.010
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.990	0.010
T46.7 Peripheral vasodilators	0.000	0.990	0.010
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.990	0.010
M54.56 Low back pain (Lumbar region)	0.010	0.990	0.000
M54.5 Low back pain	0.009	0.991	0.000
M54 Dorsalgia	0.009	0.991	0.000
M54.58 Low back pain (Sacral and sacrococcygeal region)	0.009	0.991	0.000
M54.55 Low back pain (Thoracolumbar region)	0.009	0.991	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.991	0.009
C82.3 Follicular lymphoma grade IIIa	0.009	0.991	0.000
F25 Schizoaffective disorders	0.000	0.991	0.009
M54.6 Pain in thoracic spine	0.009	0.991	0.000
M54.35 Sciatica (Thoracolumbar region)	0.008	0.991	0.000
M54.34 Sciatica-Thoracic	0.008	0.991	0.000
M54.33 Sciatica-Cervicothoracic	0.008	0.991	0.000
M54.32 Sciatica-Cervical	0.008	0.991	0.000
M54.31 Sciatica-Occipit-atl-axl	0.008	0.991	0.000
C82.4 Follicular lymphoma grade IIIb	0.008	0.992	0.000
M54.64 Pain in thoracic spine (Thoracic region)	0.008	0.992	0.000
C82.0 Small cleaved cell, follicular	0.008	0.992	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.008	0.992	0.000
M54.39 Sciatica (Site unspecified)	0.008	0.992	0.000
M54.8 Other dorsalgia	0.008	0.992	0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia	0.000	0.992	0.008
C82.2 Large cell, follicular	0.008	0.992	0.000
F23.9 Acute and transient psychotic disorder, unspecified	0.000	0.992	0.008
F23.8 Other acute and transient psychotic disorders	0.000	0.992	0.007
F23.2 Acute schizophrenia-like psychotic disorder	0.000	0.992	0.007
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.007	0.992	0.000
F25.0 Schizoaffective disorder, manic type	0.000	0.992	0.007
G30.9 Alzheimer's disease, unspecified	0.007	0.993	0.000
C82.6 Cutaneous follicle centre lymphoma	0.007	0.993	0.000
C82.5 Diffuse follicle centre lymphoma	0.007	0.993	0.000
F23.3 Other acute predominantly delusional psychotic disorders	0.000	0.993	0.007
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia	0.000	0.993	0.007
M54.2 Cervicalgia	0.007	0.993	0.000
M54.86 Other dorsalgia (Lumbar region)	0.007	0.993	0.000
M54.53 Low back pain-Cervicothoracic	0.007	0.993	0.000
M54.52 Low back pain-Cervical	0.007	0.993	0.000
M54.51 Low back pain-Occipit-atl-axl	0.007	0.993	0.000
M54.0 Panniculitis affecting regions of neck and back	0.007	0.993	0.000
T66-T78 Other and unspecified effects of external causes	0.007	0.993	0.000
O47.0 False labour before 37 completed weeks of gestation	0.007	0.993	0.000
M54.80 Other dorsalgia (Multiple sites in spine)	0.007	0.993	0.000
M54.37 Sciatica (Lumbosacral region)	0.007	0.993	0.000
F25.8 Other schizoaffective disorders	0.000	0.993	0.006
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.993	0.007
M54.69 Pain in thoracic spine-Site unspe	0.006	0.994	0.000
M54.68 Pain in thoracic spine-Sacral/sacrococ	0.006	0.994	0.000
M54.67 Pain in thoracic spine-Lumbosacral	0.006	0.994	0.000
M54.66 Pain in thoracic spine-Lumbar	0.006	0.994	0.000
M54.65 Pain in thoracic spine (Thoracolumbar region)	0.006	0.994	0.000
M54.63 Pain in thoracic spine (Cervicothoracic region)	0.006	0.994	0.000
M54.62 Pain in thoracic spine-Cervical	0.006	0.994	0.000
M54.61 Pain in thoracic spine-Occipit-atl-axl	0.006	0.994	0.000
M54.60 Pain in thoracic spine (Multiple sites in spine)	0.006	0.994	0.000
M54.28 Cervicalgia-Sacral/sacrococ	0.006	0.994	0.000
M54.84 Other dorsalgia (Thoracic region)	0.006	0.994	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.994	0.006
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.994	0.006
F25.2 Schizoaffective disorder, mixed type	0.000	0.994	0.006
M54.88 Other dorsalgia (Sacral and sacrococcygeal region)	0.006	0.994	0.000
M54.54 Low back pain-Thoracic	0.006	0.994	0.000
M54.4 Lumbago with sciatica	0.006	0.994	0.000
M54.85 Other dorsalgia (Thoracolumbar region)	0.006	0.994	0.000
M54.83 Other dorsalgia (Cervicothoracic region)	0.006	0.994	0.000
M54.82 Other dorsalgia (Cervical region)	0.006	0.994	0.000
M54.81 Other dorsalgia (Occipito-atlanto-axial region)	0.006	0.994	0.000
M54.87 Other dorsalgia (Lumbosacral region)	0.006	0.994	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.994	0.006
F00.9 Dementia in Alzheimer's disease, unspecified	0.006	0.994	0.000
F25.1 Schizoaffective disorder, depressive type	0.000	0.994	0.005
M54.23 Cervicalgia (Cervicothoracic region)	0.005	0.994	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.994	0.006
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.994	0.006
S42.40 Fracture of lower end of humerus (closed)	0.000	0.994	0.006
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.994	0.006
M54.27 Cervicalgia-Lumbosacral	0.005	0.995	0.000
M54.26 Cervicalgia-Lumbar	0.005	0.995	0.000
M54.25 Cervicalgia-Thoracolumbar	0.005	0.995	0.000
M54.24 Cervicalgia-Thoracic	0.005	0.995	0.000
M54.21 Cervicalgia (Occipito-atlanto-axial region)	0.005	0.995	0.000
M54.20 Cervicalgia-Mult site	0.005	0.995	0.000
G31.8 Other specified degenerative diseases of nervous system	0.000	0.995	0.005
M54.57 Low back pain (Lumbosacral region)	0.005	0.995	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.995	0.005
M54.29 Cervicalgia-Site unspe	0.005	0.995	0.000
F25.9 Schizoaffective disorder, unspecified	0.000	0.995	0.005
T45.2 Vitamins, not elsewhere classified	0.000	0.995	0.005
T38.1 Thyroid hormones and substitutes	0.000	0.995	0.005
T47.2 Stimulant laxatives	0.000	0.995	0.005
M54.09 Panniculitis affecting regions of neck and back (Site unspecified)	0.005	0.995	0.000
M54.08 Panniculitis affecting regions of neck and back (Sacral and sacrococcygeal region)	0.005	0.995	0.000
M54.07 Panniculitis affecting regions of neck and back (Lumbosacral region)	0.005	0.995	0.000
M54.06 Panniculitis affecting regions of neck and back (Lumbar region)	0.005	0.995	0.000
M54.05 Panniculitis affecting regions of neck and back (Thoracolumbar region)	0.005	0.995	0.000
M54.04 Panniculitis affecting regions of neck and back (Thoracic region)	0.005	0.995	0.000
M54.03 Panniculitis affecting regions of neck and back (Cervicothoracic region)	0.005	0.995	0.000
M54.02 Panniculitis affecting regions of neck and back (Cervical region)	0.005	0.995	0.000
M54.01 Panniculitis affecting regions of neck and back (Occipito-atlanto-axial region)	0.005	0.995	0.000
M54.00 Panniculitis affecting regions of neck and back (Multiple sites in spine)	0.005	0.995	0.000
T47.4 Other laxatives	0.000	0.995	0.005
T47.0 Histamine H(2)-receptor antagonists	0.000	0.995	0.005
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.995	0.005
T74 Maltreatment syndromes	0.005	0.995	0.000
T73 Effects of other deprivation	0.005	0.995	0.000
T69 Other effects of reduced temperature	0.005	0.995	0.000
T67 Effects of heat and light	0.005	0.995	0.000
M54.17 Radiculopathy (Lumbosacral region)	0.005	0.995	0.000
T75 Effects of other external causes	0.005	0.995	0.000
T47.6 Antidiarrhoeal drugs	0.000	0.995	0.005
T45.5 Anticoagulants	0.000	0.995	0.005
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.995	0.005
M54.9 Dorsalgia, unspecified	0.005	0.995	0.000
S82.1 Fracture of upper end of tibia	0.000	0.995	0.005
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.995	0.005
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.995	0.005
T45.8 Other primarily systemic and haematological agents	0.000	0.995	0.005
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.995	0.005
T45.6 Fibrinolysis-affecting drugs	0.000	0.995	0.005
T45.4 Iron and its compounds	0.000	0.995	0.005
T45.3 Enzymes, not elsewhere classified	0.000	0.995	0.005
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.000	0.995	0.005
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.995	0.005
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.995	0.005
T47.7 Emetics	0.000	0.995	0.005
T47.5 Digestants	0.000	0.995	0.005
T47.3 Saline and osmotic laxatives	0.000	0.995	0.005
T70 Effects of air pressure and water pressure	0.005	0.995	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.995	0.005
T36 Poisoning by systemic antibiotics	0.000	0.995	0.005
M54.1 Radiculopathy	0.005	0.995	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.995	0.005
M54.49 Lumbago with sciatica (Site unspecified)	0.005	0.995	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.995	0.005
M54.47 Lumbago with sciatica (Lumbosacral region)	0.005	0.995	0.000
M54.50 Low back pain (Multiple sites in spine)	0.004	0.995	0.000
K29.4 Chronic atrophic gastritis	0.000	0.995	0.005
M54.48 Lumbago with sciatica (Sacral and sacrococcygeal region)	0.004	0.995	0.000
M54.45 Lumbago with sciatica (Thoracolumbar region)	0.004	0.995	0.000
M54.44 Lumbago with sciatica-Thoracic	0.004	0.995	0.000
M54.43 Lumbago with sciatica-Cervicothoracic	0.004	0.995	0.000
M54.42 Lumbago with sciatica-Cervical	0.004	0.995	0.000
M54.41 Lumbago with sciatica-Occipit-atl-axl	0.004	0.995	0.000
M54.40 Lumbago with sciatica (Multiple sites in spine)	0.004	0.995	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.995	0.004
T71 Asphyxiation	0.004	0.995	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.996	0.004
Z52.4 Kidney donor	0.004	0.996	0.000
M54.95 Dorsalgia, unspecified (Thoracolumbar region)	0.004	0.996	0.000
K27.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.000	0.996	0.004
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.996	0.004
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.996	0.004
M54.89 Other dorsalgia (Site unspecified)	0.004	0.996	0.000
I22.9 Subsequent myocardial infarction of unspecified site	0.000	0.996	0.004
T50.4 Drugs affecting uric acid metabolism	0.000	0.996	0.004
T50.1 Loop [high-ceiling] diuretics	0.000	0.996	0.004
M47.26 Other spondylosis with radiculopathy (Lumbar region)	0.004	0.996	0.000
M54.98 Dorsalgia, unspecified (Sacral and sacrococcygeal region)	0.004	0.996	0.000
T68 Hypothermia	0.004	0.996	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.996	0.004
T38.7 Androgens and anabolic congeners	0.000	0.996	0.004
T38.5 Other oestrogens and progestogens	0.000	0.996	0.004
T38.4 Oral contraceptives	0.000	0.996	0.004
T38.2 Antithyroid drugs	0.000	0.996	0.004
T38.0 Glucocorticoids and synthetic analogues	0.000	0.996	0.004
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.996	0.004
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.996	0.004
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.996	0.004
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.004
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.996	0.004
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.996	0.004
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.996	0.004
T44.0 Anticholinesterase agents	0.000	0.996	0.004
T75.4 Effects of electric current	0.004	0.996	0.000
T66 Unspecified effects of radiation	0.004	0.996	0.000
T50.7 Analeptics and opioid receptor antagonists	0.000	0.996	0.004
T50.5 Appetite depressants	0.000	0.996	0.004
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.996	0.004
T50.0 Mineralocorticoids and their antagonists	0.000	0.996	0.004
M23.29 Derangement of meniscus due to old tear or injury (Unspecified ligament or Unspecified meniscus)	0.004	0.996	0.000
R00.8 Other and unspecified abnormalities of heart beat	0.000	0.996	0.004
T50.8 Diagnostic agents	0.000	0.996	0.004
Z83.7 Family history of diseases of the digestive system	0.000	0.996	0.004
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.996	0.004
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.996	0.004
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.996	0.004
H18.4 Corneal degeneration	0.000	0.996	0.004
Z50.5 Speech therapy	0.000	0.996	0.004
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.000	0.996	0.004
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.996	0.004
M54.22 Cervicalgia (Cervical region)	0.004	0.996	0.000
M54.97 Dorsalgia, unspecified (Lumbosacral region)	0.004	0.996	0.000
H47.3 Other disorders of optic disk	0.004	0.996	0.000
M88.9 Paget's disease of bone, unspecified	0.000	0.996	0.004
M54.93 Dorsalgia, unspecified (Cervicothoracic region)	0.004	0.996	0.000
T49.9 Topical agent, unspecified	0.000	0.996	0.004
T49.8 Other topical agents	0.000	0.996	0.004
T49.7 Dental drugs, topically applied	0.000	0.996	0.004
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.996	0.004
T49.5 Ophthalmological drugs and preparations	0.000	0.996	0.004
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.996	0.004
T49.3 Emollients, demulcents and protectants	0.000	0.996	0.004
T49.2 Local astringents and local detergents	0.000	0.996	0.004
T49.1 Antipruritics	0.000	0.996	0.004
T67.9 Effects of heat and light, unspecified	0.004	0.996	0.000
T67.8 Other effects of heat and light	0.004	0.996	0.000
T67.7 Heat oedema	0.004	0.996	0.000
T67.6 Heat fatigue, transient	0.004	0.996	0.000
T67.5 Heat exhaustion, unspecified	0.004	0.996	0.000
T67.4 Heat exhaustion due to salt depletion	0.004	0.996	0.000
T67.3 Heat exhaustion, anhydrotic	0.004	0.996	0.000
T67.2 Heat cramp	0.004	0.996	0.000
T67.1 Heat syncope	0.004	0.996	0.000
T67.0 Heatstroke and sunstroke	0.004	0.996	0.000
T69.9 Effect of reduced temperature, unspecified	0.004	0.996	0.000
T69.8 Other specified effects of reduced temperature	0.004	0.996	0.000
T69.1 Chilblains	0.004	0.996	0.000
T69.0 Immersion hand and foot	0.004	0.996	0.000
T73.9 Effect of deprivation, unspecified	0.004	0.996	0.000
T73.8 Other effects of deprivation	0.004	0.996	0.000
T73.3 Exhaustion due to excessive exertion	0.004	0.996	0.000
T73.2 Exhaustion due to exposure	0.004	0.996	0.000
T73.1 Effects of thirst	0.004	0.996	0.000
T73.0 Effects of hunger	0.004	0.996	0.000
T74.9 Maltreatment syndrome, unspecified	0.004	0.996	0.000
T74.8 Other maltreatment syndromes	0.004	0.996	0.000
T74.3 Psychological abuse	0.004	0.996	0.000
T74.2 Sexual abuse	0.004	0.996	0.000
T74.1 Physical abuse	0.004	0.996	0.000
T74.0 Neglect or abandonment	0.004	0.996	0.000
T75.8 Other specified effects of external causes	0.004	0.996	0.000
T75.3 Motion sickness	0.004	0.996	0.000
T75.2 Effects of vibration	0.004	0.996	0.000
T75.0 Effects of lightning	0.004	0.996	0.000
M54.96 Dorsalgia, unspecified (Lumbar region)	0.004	0.996	0.000
Z11.5 Special screening examination for other viral diseases	0.000	0.996	0.004
M54.91 Dorsalgia, unspecified (Occipito-atlanto-axial region)	0.004	0.996	0.000
T41.5 Therapeutic gases	0.000	0.996	0.004
T41.4 Anaesthetic, unspecified	0.000	0.996	0.004
T41.3 Local anaesthetics	0.000	0.996	0.004
T41.2 Other and unspecified general anaesthetics	0.000	0.996	0.004
T41.1 Intravenous anaesthetics	0.000	0.996	0.004
T41.0 Inhaled anaesthetics	0.000	0.996	0.004
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified	0.000	0.996	0.004
M54.14 Radiculopathy (Thoracic region)	0.004	0.996	0.000
M54.92 Dorsalgia, unspecified (Cervical region)	0.004	0.996	0.000
Z11.2 Special screening examination for other bacterial diseases	0.000	0.996	0.004
B01 Varicella [chickenpox]	0.000	0.996	0.004
X41.9 Unspecified place	0.000	0.996	0.004
M88.99 Paget's disease of bone, unspecified (Site unspecified)	0.000	0.996	0.004
T70.9 Effect of air pressure and water pressure, unspecified	0.003	0.996	0.000
T70.8 Other effects of air pressure and water pressure	0.003	0.996	0.000
T70.4 Effects of high-pressure fluids	0.003	0.996	0.000
T70.2 Other and unspecified effects of high altitude	0.003	0.996	0.000
T70.1 Sinus barotrauma	0.003	0.996	0.000
T70.0 Otitic barotrauma	0.003	0.996	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.996	0.003
T36.8 Other systemic antibiotics	0.000	0.996	0.003
T36.7 Antifungal antibiotics, systemically used	0.000	0.996	0.003
T36.6 Rifamycins	0.000	0.996	0.003
T36.5 Aminoglycosides	0.000	0.996	0.003
T36.4 Tetracyclines	0.000	0.996	0.003
T36.3 Macrolides	0.000	0.996	0.003
T36.2 Chloramphenicol group	0.000	0.996	0.003
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.996	0.003
M54.15 Radiculopathy (Thoracolumbar region)	0.004	0.996	0.000
M54.13 Radiculopathy (Cervicothoracic region)	0.004	0.996	0.000
M54.11 Radiculopathy (Occipito-atlanto-axial region)	0.004	0.996	0.000
M54.10 Radiculopathy (Multiple sites in spine)	0.004	0.996	0.000
B01.9 Varicella without complications	0.000	0.996	0.004
S64.3 Injury of digital nerve of thumb	0.004	0.996	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.996	0.003
S82.11 Fracture of upper end of tibia (open)	0.000	0.996	0.003
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.996	0.003
T37.5 Antiviral drugs	0.000	0.996	0.003
T37.4 Anthelminthics	0.000	0.996	0.003
T37.3 Other antiprotozoal drugs	0.000	0.996	0.003
T37.1 Antimycobacterial drugs	0.000	0.996	0.003
T37.0 Sulphonamides	0.000	0.996	0.003
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.004
M54.94 Dorsalgia, unspecified (Thoracic region)	0.003	0.996	0.000
T40.6 Other and unspecified narcotics	0.000	0.996	0.003
T36.0 Penicillins	0.000	0.997	0.003
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.997	0.003
T48.4 Expectorants	0.000	0.997	0.003
T48.3 Antitussives	0.000	0.997	0.003
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.997	0.003
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.997	0.003
T48.0 Oxytocic drugs	0.000	0.997	0.003
T75.1 Drowning and nonfatal submersion	0.003	0.997	0.000
S42.4 Fracture of lower end of humerus	0.000	0.997	0.003
B08 Other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified	0.000	0.997	0.003
M88.95 Paget's disease of bone, unspecified (Pelvic region and thigh)	0.000	0.997	0.003
Z11.4 Special screening examination for human immunodeficiency virus [HIV]	0.000	0.997	0.003
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.997	0.003
T40.8 Lysergide [LSD]	0.000	0.997	0.003
T40.7 Cannabis (derivatives)	0.000	0.997	0.003
T40.3 Methadone	0.000	0.997	0.003
T40.0 Opium	0.000	0.997	0.003
T40.2 Other opioids	0.000	0.997	0.003
T70.3 Caisson disease [decompression sickness]	0.003	0.997	0.000
E78.8 Other disorders of lipoprotein metabolism	0.003	0.997	0.000
Z50.4 Psychotherapy, not elsewhere classified	0.000	0.997	0.003
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.997	0.003
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.997	0.003
T40.1 Heroin	0.000	0.997	0.003
T40.5 Cocaine	0.000	0.997	0.003
Z91.5 Personal history of self-harm	0.000	0.997	0.003
B06 Rubella [German measles]	0.000	0.997	0.003
B05 Measles	0.000	0.997	0.003
B09 Unspecified viral infection characterised by skin and mucous membrane lesions	0.000	0.997	0.003
B04 Monkeypox	0.000	0.997	0.003
B03 Smallpox	0.000	0.997	0.003
M54.46 Lumbago with sciatica (Lumbar region)	0.003	0.997	0.000
T48.5 Anti-common-cold drugs	0.000	0.997	0.003
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.997	0.003
M23.49 Loose body in knee-Unspec lig/men	0.003	0.997	0.000
M88.98 Paget's disease of bone, unspecified (Other)	0.000	0.997	0.003
M88.97 Paget's disease of bone, unspecified (Ankle and foot)	0.000	0.997	0.003
M88.96 Paget's disease of bone, unspecified (Lower leg)	0.000	0.997	0.003
M88.94 Paget's disease of bone, unspecified (Hand)	0.000	0.997	0.003
M88.93 Paget's disease of bone, unspecified (Forearm)	0.000	0.997	0.003
M88.92 Paget's disease of bone, unspecified (Upper arm)	0.000	0.997	0.003
M88.91 Paget's disease of bone, unspecified (Shoulder region)	0.000	0.997	0.003
B01.8 Varicella with other complications	0.000	0.997	0.003
G53.0 Postzoster neuralgia	0.000	0.997	0.003
G30 Alzheimer's disease	0.003	0.997	0.000
S42.41 Fracture of lower end of humerus (open)	0.000	0.997	0.003
B01.1 Varicella encephalitis	0.000	0.997	0.003
B01.0 Varicella meningitis	0.000	0.997	0.003
B08.1 Molluscum contagiosum	0.000	0.997	0.003
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.000	0.997	0.003
I22.1 Subsequent myocardial infarction of inferior wall	0.000	0.997	0.003
G31.2 Degeneration of nervous system due to alcohol	0.000	0.997	0.003
M54.12 Radiculopathy (Cervical region)	0.003	0.997	0.000
Z50 Care involving use of rehabilitation procedures	0.000	0.997	0.003
Z11 Special screening examination for infectious and parasitic diseases	0.000	0.997	0.003
F52.2 Failure of genital response	0.000	0.997	0.003
B01.2 Varicella pneumonia	0.000	0.997	0.003
S40.9 Superficial injury of shoulder and upper arm, unspecified	0.000	0.997	0.003
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.997	0.003
B08.8 Other specified viral infections characterised by skin and mucous membrane lesions	0.000	0.997	0.003
B08.5 Enteroviral vesicular pharyngitis	0.000	0.997	0.003
B08.4 Enteroviral vesicular stomatitis with exanthem	0.000	0.997	0.003
B08.3 Erythema infectiosum [fifth disease]	0.000	0.997	0.003
B08.2 Exanthema subitum [sixth disease]	0.000	0.997	0.003
B08.0 Other orthopoxvirus infections	0.000	0.997	0.003
Z50.2 Alcohol rehabilitation	0.000	0.997	0.003
T40.4 Other synthetic narcotics	0.000	0.997	0.003
M54.18 Radiculopathy (Sacral and sacrococcygeal region)	0.002	0.997	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.997	0.003
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.997	0.003
T42.3 Barbiturates	0.000	0.997	0.003
T42.2 Succinimides and oxazolidinediones	0.000	0.997	0.003
M54.19 Radiculopathy (Site unspecified)	0.002	0.997	0.000
H47.2 Optic atrophy	0.003	0.997	0.000
I22 Subsequent myocardial infarction	0.000	0.997	0.003
B05.9 Measles without complication	0.000	0.997	0.002
B05.8 Measles with other complications	0.000	0.997	0.002
B05.4 Measles with intestinal complications	0.000	0.997	0.002
B05.3 Measles complicated by otitis media	0.000	0.997	0.002
B05.2 Measles complicated by pneumonia	0.000	0.997	0.002
B05.1 Measles complicated by meningitis	0.000	0.997	0.002
B05.0 Measles complicated by encephalitis	0.000	0.997	0.002
B06.9 Rubella without complication	0.000	0.997	0.002
B06.8 Rubella with other complications	0.000	0.997	0.002
B06.0 Rubella with neurological complications	0.000	0.997	0.002
C50.5 Lower-outer quadrant of breast	0.003	0.997	0.000
T42.4 Benzodiazepines	0.000	0.997	0.003
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.997	0.002
M54.90 Dorsalgia, unspecified (Multiple sites in spine)	0.002	0.997	0.000
Z99.1 Dependence on respirator	0.000	0.997	0.003
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
G31.1 Senile degeneration of brain, not elsewhere classified	0.000	0.998	0.002
G30.1 Alzheimer's disease with late onset	0.002	0.998	0.000
G30.0 Alzheimer's disease with early onset	0.002	0.998	0.000
F60.3 Emotionally unstable personality disorder	0.000	0.998	0.002
Z50.9 Care involving use of rehabilitation procedure, unspecified	0.000	0.998	0.002
Z50.6 Orthoptic training	0.000	0.998	0.002
H47 Other disorders of optic [2nd] nerve and visual pathways	0.002	0.998	0.000
Z11.3 Special screening examination for infections with a predominantly sexual mode of transmission	0.000	0.998	0.002
Z11.6 Special screening examination for other protozoal diseases and helminthiases	0.000	0.998	0.002
E21.3 Hyperparathyroidism, unspecified	0.002	0.998	0.000
M96.1 Postlaminectomy syndrome, not elsewhere classified	0.000	0.998	0.002
G31.9 Degenerative disease of nervous system, unspecified	0.000	0.998	0.002
G91.9 Hydrocephalus, unspecified	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.000	0.998	0.002
E04.9 Non-toxic goitre, unspecified	0.000	0.998	0.002
F52 Sexual dysfunction, not caused by organic disorder or disease	0.000	0.998	0.002
E80.4 Gilbert's syndrome	0.002	0.998	0.000
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.000	0.998	0.002
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.000	0.998	0.002
I22.8 Subsequent myocardial infarction of other sites	0.000	0.998	0.002
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.000	0.998	0.002
Z11.9 Special screening examination for infectious and parasitic diseases, unspecified	0.000	0.998	0.002
Y84.0 Cardiac catheterisation	0.000	0.998	0.002
Z50.3 Drug rehabilitation	0.000	0.998	0.002
S02.00 Fracture of vault of skull (closed)	0.000	0.998	0.002
H25.9 Senile cataract, unspecified	0.000	0.998	0.002
K25.3 Acute without haemorrhage or perforation	0.000	0.998	0.002
O61.0 Failed medical induction of labour	0.000	0.998	0.002
G30.8 Other Alzheimer's disease	0.001	0.998	0.001
B00 Herpesviral [herpes simplex] infections	0.000	0.998	0.002
F52.0 Lack or loss of sexual desire	0.000	0.998	0.002
Z52.0 Blood donor	0.002	0.998	0.000
F00 Dementia in Alzheimer's disease	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
M96.0 Pseudarthrosis after fusion or arthrodesis	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
B95.0 Streptococcus, group A, as the cause of diseases classified to other chapters	0.000	0.998	0.002
J80 Adult respiratory distress syndrome	0.000	0.998	0.002
B99 Other and unspecified infectious diseases	0.002	0.998	0.000
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
Z52 Donors of organs and tissues	0.002	0.998	0.000
H47.7 Disorder of visual pathways, unspecified	0.002	0.998	0.000
H47.6 Disorders of visual cortex	0.002	0.998	0.000
H47.5 Disorders of other visual pathways	0.002	0.998	0.000
H47.4 Disorders of optic chiasm	0.002	0.998	0.000
O41.8 Other specified disorders of amniotic fluid and membranes	0.000	0.998	0.002
Z11.1 Special screening examination for respiratory tuberculosis	0.000	0.998	0.002
M23.43 Loose body in knee-Med lig/oth men	0.002	0.998	0.000
M23.4 Loose body in knee	0.002	0.998	0.000
H47.0 Disorders of optic nerve, not elsewhere classified	0.002	0.998	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
Z11.8 Special screening examination for other infectious and parasitic diseases	0.000	0.998	0.002
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.002
C71.1 Frontal lobe	0.000	0.998	0.002
M88 Paget's disease of bone [osteitis deformans]	0.000	0.998	0.002
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease	0.000	0.998	0.002
F52.8 Other sexual dysfunction, not caused by organic disorder or disease	0.000	0.998	0.002
F52.7 Excessive sexual drive	0.000	0.998	0.002
F52.6 Nonorganic dyspareunia	0.000	0.998	0.002
F52.5 Nonorganic vaginismus	0.000	0.998	0.002
F52.4 Premature ejaculation	0.000	0.998	0.002
F52.3 Orgasmic dysfunction	0.000	0.998	0.002
F52.1 Sexual aversion and lack of sexual enjoyment	0.000	0.998	0.002
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.998	0.002
L85.9 Epidermal thickening, unspecified	0.002	0.998	0.000
S01.5 Open wound of lip and oral cavity	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
J84.9 Interstitial pulmonary disease, unspecified	0.000	0.998	0.002
M88.8 Paget's disease of other bones	0.000	0.998	0.002
N42.1 Congestion and haemorrhage of prostate	0.002	0.998	0.000
S40.8 Other superficial injuries of shoulder and upper arm	0.000	0.998	0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
Z83.4 Family history of other endocrine, nutritional and metabolic diseases	0.000	0.998	0.002
M96 Postprocedural musculoskeletal disorders, not elsewhere classified	0.000	0.998	0.002
M88.85 Paget's disease of other bones (Pelvic region and thigh)	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations